About this trial
In this project, the investigators will implement innovations to extend use of Contingency Management (CM) to facilitate alcohol use reduction among people living with HIV (PLWH). The investigators' approach to extending CM will use mobile health (mHealth) tools including a smartphone breathalyzer device with accompanying app and a wrist worn alcohol biosensor. Participants will be engaged in mobile facilitated CM for 30-60 days with follow-up out to 6 months.
Eligibility criteria
Qualifiers
Frequent alcohol use in the past 30 days based on responses on the Timeline Followback (TLFB; Sobell and Sobell, 2003)
HIV positive
Fluency in English
Willingness to attempt alcohol abstinence for at least 30 days and then to attempt alcohol use on fewer days than at baseline after that
Disqualifiers
Psychiatric conditions that would interfere with participation in the study
Current alcohol withdrawal as indicated by a score of 8 or higher on the Clinical Institute Withdrawal Scale (CIWA; Sullivan et al., 1989) or lifetime history of medically assisted detoxification
Two positive breath alcohol concentration (BrAC) readings (i.e., > 0.00%) at an in-person screening appointment. After participants blow their first positive BrAC, they will be allowed to reschedule and participate at another time, however if they blow a second positive BrAC, they will be excluded from this study and offered referrals for alcohol treatment.
Currently seeking or past-12-month history of inpatient or intensive treatment for addictive behaviors
Trial design
Treatments tested in this trial
- Counseling
- mHealth
- Counseling
Treatment groups
Sponsors and collaborators
University of Florida
Lead sponsor
University of Miami
Collaborator
University of Louisville
Collaborator
Florida State University
Collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator